Health
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle COVID-19 Vaccine – The Korea Herald
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory…
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in Indonesia and Philippines for Novavax’ recombinant nanoparticle COVID-19 vaccine
– Filing for World Health Organization…
Continue Reading
-
General16 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News16 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General19 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News18 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland